Lyell Immunopharma, Inc. (NASDAQ:LYEL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Heather Turner Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); LB Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 10, 2025); Terns Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2024); Sangamo Therapeutics, Inc. (EVP, General Counsel & Sec. · Feb 12, 2018 – Feb 25, 2019 · Past); Atara Biotherapeutics, Inc. (Former EVP, GC & Sec. · Feb 6, 2018 – Feb 9, 2018 · Past) | Chief General Counsel · Jun 16, 2021 – Mar 16, 2022 · Past |
| Charles Newton Other companies: Keros Therapeutics, Inc. (Director · Since at least Feb 26, 2026); Novavax, Inc. (Director · Since at least Apr 25, 2025); Coherus Oncology, Inc. (Director · Since at least May 4, 2022); 2Seventy Bio Inc (Director · Mar 20, 2024 – May 13, 2025 · Past) | Chief Financial Officer · Since at least Jun 16, 2021 |
| Hans Bishop Other companies: Sana Biotechnology, Inc. (Chairman · Since at least Feb 3, 2021); Celgene Corporation (Director · Apr 18, 2018 – Nov 20, 2019 · Past); Agilent Technologies, Inc. (Director · Jul 18, 2017 – Mar 15, 2024 · Past); Juno Therapeutics Inc (CEO & President, Director · Jun 9, 2016 – Mar 5, 2018 · Past) | Director · Jun 16, 2021 – Jun 14, 2024 · Past |
| Otis W. Brawley Other companies: Agilent Technologies, Inc. (Director · Since at least Nov 17, 2021); Incyte Corporation (Director · Since at least Sep 27, 2021); PDS Biotechnology Corporation (Director · Since at least Nov 3, 2020); Theragenics Corp (Director · May 9, 2006 – May 18, 2007 · Past) | Director · Since at least Jun 16, 2021 |
| Cathy Friedman Other companies: Revolution Healthcare Acquisition Corp (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Seer, Inc. (Director · Dec 3, 2020 – Jun 14, 2023 · Past); Radius Health, Inc. (Director · Feb 20, 2020 – Aug 15, 2022 · Past) | Director · Since at least Jun 16, 2021 |
| Elizabeth Nabel Other companies: Moderna, Inc. (Director · Since at least Dec 7, 2018); Medtronic plc. (Director · Since at least Sep 16, 2014); Accolade, Inc. (Director · Jun 2, 2021 – Apr 8, 2025 · Past) | Director · Since at least Jun 16, 2021 |
| Lynn Seely Other companies: AbCellera Biologics Inc. (Director · Since at least Jun 30, 2026); Blueprint Medicines Corp (Director · Since at least Jun 19, 2019); Myovant Sciences Ltd (Principal Executive Officer, Director · Apr 5, 2019 – Apr 3, 2020 · Past) | President and CEO, Director · Since at least Jun 16, 2021 |
| Matthew Lang Other companies: Structure Therapeutics, Inc. (COO & GC · Since at least Apr 15, 2026); Metsera, Inc. (CHIEF LEGAL OFFICER · Since at least Apr 28, 2025); Myovant Sciences Ltd (General Counsel & Corp. Secy. · Apr 5, 2019 – Mar 10, 2023 · Past) | Chief Business Officer · Jul 1, 2023 – Feb 10, 2025 · Past |
| William Rieflin Other companies: RAPT Therapeutics Inc (Director · Oct 30, 2019 – May 22, 2024 · Past); NGM Biopharmaceuticals Inc (Director · Apr 3, 2019 – Apr 5, 2024 · Past); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past) | Director · Since at least Jun 16, 2021 |
| Mark Meltz Other companies: Kinnate Biopharma Inc (COO GENERAL COUNSEL SECRETARY · Dec 2, 2020 – Apr 3, 2024 · Past); Audentes Therapeutics Inc (SVP, General Counsel · Mar 28, 2019 – Jan 15, 2020 · Past) | General Counsel and Corporate Secretary · Since at least Jun 9, 2025 |
| David Shook Other companies: Nkarta, Inc. (See Remarks · Jan 1, 2023 – Jan 15, 2025 · Past) | Chief Medical Officer · Since at least Jun 9, 2025 |
| Ellen Rose Other companies: LB Pharmaceuticals Inc (Senior Vice President, Corporate Affairs · Since at least Oct 15, 2026) | Senior Vice President, Communications and Investor Relations · Since at least Dec 7, 2025 |
| Mark J. Bachleda Other companies: Galera Therapeutics, Inc. (Chief Commercial Officer · Oct 8, 2021 – Mar 16, 2023 · Past) | Director · Since at least Jun 9, 2025 |
| Richard Klausner Other companies: Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026) | Director · Since at least Jun 8, 2021 |
| Rick Klausner Other companies: Parabilis Medicines, Inc. (Founder and Chief Scientist Altos Labs, Inc. · Since at least Nov 4, 2026) | Founder & Chairman of the Board · Since at least Jun 9, 2025 |
| Ann Tomlin | Chief Human Resource Officer · Since at least Nov 5, 2026 |
| Bryan Selby | Senior Vice President, Clinical Development Operations · Since at least Nov 5, 2026 |
| Catherine Friedman | Director · Since at least Nov 5, 2026 |
| Elizabeth Homans | Chief Executive Officer, Director · Jun 16, 2021 – Mar 16, 2022 · Past |
| Gary Lee | Chief Scientific Officer · Since at least Nov 16, 2023 |
| Jarrad Aguirre | Chief Medical Officer · Since at least Jun 9, 2025 |
| Pablo Fenton | Associate Director, Investor Relations and Corporate Communications · Since at least Aug 6, 2026 |
| Pablo FentonAssociate | Director, Investor Relations and Corporate · Since at least Jun 4, 2026 |
| Peter A. Prieto | Senior Vice President, Medical Affairs · Since at least Nov 5, 2026 |
| Smital Shah | Chief Financial and Business Officer · Since at least Mar 12, 2026 |
| Stephen Hill | Chief Operating Officer · Since at least Jun 16, 2021 |
| Sumant Ramachandra | Director · Since at least Oct 31, 2024 |
| Veronica Sanchez Bulis | VP, Corporate Controller · Since at least Oct 31, 2025 |